Friday, March 6, 2026
7:30 AM - 8:30 AM
Registration & Networking
7:30 AM - 8:30 AM
Breakfast
8:30 AM - 8:50 AM
Designing Clinical Trials, Validating Biomarkers, and Integrating AI
8:30 AM - 8:50 AM
Welcome & Opening Remarks
8:50 AM - 9:10 AM
Overview of Consensus Process
8:50 AM - 9:10 AM
Delphi Framework and Objectives
9:10 AM - 9:30 AM
Plenary Kickoff Talk
9:10 AM - 9:30 AM

State of the Art Lecture

9:30 AM - 10:00 AM
Break
9:30 AM - 10:00 AM
Coffee Break
10:00 AM - 12:30 PM
Parallel Session I Clinical Trial Design
10:00 AM - 12:30 PM
Alcohol-Related Liver Disease: Ethical trial frameworks for early LT and relapse
Parallel Session I Clinical Trial Design
10:00 AM - 12:30 PM
Machine Perfusion: Trial structures and endpoints for perfusion
Parallel Session I Clinical Trial Design
10:00 AM - 12:30 PM
Hepatocellular Carcinoma: Harmonizing trial endpoints and eligibility
12:30 PM - 1:30 PM
Break
12:30 PM - 1:30 PM
Sponsored Lunch Symposium
1:30 PM - 3:30 PM
Parallel Sessions II – Biomarkers
1:30 PM - 3:30 PM
Alcohol-Related Liver Disease: Biomarkers for relapse risk and injury differentiation
Parallel Sessions II – Biomarkers
1:30 PM - 3:30 PM
Hepatocellular Carcinoma: Biomarker pipelines for clinical qualification
Parallel Sessions II – Biomarkers
1:30 PM - 3:30 PM
Machine Perfusion: Predictive biomarkers of graft function
4:00 PM - 5:30 PM
Parallel Sessions III – AI & Data Integration
4:00 PM - 5:30 PM
Hepatocellular Carcinoma: AI for recurrence prediction and imaging
Parallel Sessions III – AI & Data Integration
4:00 PM - 5:30 PM
Machine Perfusion: AI for decision support in perfusion
Parallel Sessions III – AI & Data Integration
4:00 PM - 5:30 PM
Alcohol-Related Liver Disease: AI to improve relapse prediction & ethical monitoring
5:30 PM - 6:00 PM
Day 1 Wrap Up
5:30 PM - 6:00 PM
Summary of Key Recommendations
6:30 PM - 8:00 PM
Networking Reception
6:30 PM - 8:00 PM
Dinner
Saturday, March 7, 2026
7:45 AM - 8:15 AM
From Focus to Framework – Integration, Consensus, and Adoption
7:45 AM - 8:15 AM
Sponsored Networking Breakfast
8:15 AM - 9:30 AM
Keynote Session: Innovation in Focus
8:15 AM - 9:30 AM

KEYNOTE SESSION
8:15-8:20 AM. Moderators: Valeria Mas, PhD; Wojtek Polak, MD
8:20-8:35 AM. Machine Perfusion: Trial Design and Real-Time Biomarkers. Robert Porte, MD, PhD.
8:40-8:55 AM. HCC: Precision Trials and Biomarker Validation. Neil Mehta, MD
9:00-9:15 AM Integrating Biomarkers & AI Into Ethical Trials. Patrizia Burra., MD.
9:15-9:30AM. Panel Discussion

9:30 AM - 12:45 PM
Cross-Group Synthesis Panel
9:30 AM - 12:45 PM

From Evidence to Consensus: Unified Standards for Trials, Biomarkers & AI

12:45 PM - 1:00 PM
Day 2 Wrap Up
12:45 PM - 1:00 PM

Group Photo

Time Zone: (UTC-05:00) Eastern Time (US & Canada) [Change Time Zone]